AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimter MV 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimter MV 1mg/500mg/0.2mg Tablet SR

Diabetic patients using Glimter MV 1mg/500mg/0.2mg SR tablets, an anti-diabetic combination medication, should adhere to their prescribed dosage. This medication manages type 2 diabetes in adults by regulating blood glucose. Consistent daily intake, ideally with meals, maximizes effectiveness. Dosage adjustments are determined by your physician based on blood sugar monitoring. Discontinuing treatment without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Glimter MV is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Carry a rapid-acting glucose source (e.g., juice, sweets) to counteract this. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are crucial for safe and effective treatment.

Primary Ingredients of Glimter MV 1mg/500mg/0.2mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimter MV 1mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimter MV 1mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter MV 1mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet on an empty stomach.

Common Side effects of Glimter MV 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimter MV 1mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter MV 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Glimter MV 1mg/500mg/0.2mg Tablet SR works:

Glimter MV extended-release tablets (1 mg/500 mg/0.2 mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimter MV 1mg/500mg/0.2mg SR tablets with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimter MV 1mg/500mg/0.2mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimter MV 1mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Preliminary evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glimter MV 1mg/500mg/0.2mg Tablet SR, as its use may be unsafe. A physician's consultation is advised. Furthermore, this medication is unsuitable for individuals with severe kidney impairment.

LiverLiverCAUTION

Exercise caution when prescribing Glimter MV 1mg/500mg/0.2mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate Glimter MV 1mg/500mg/0.2mg Tablet SR therapy at a reduced dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimter MV 1mg/500mg/0.2mg Tablet SR :

Should you forget a Glimter MV 1mg/500mg/0.2mg Tablet SR dose, administer it immediately upon remembering. If your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimter MV 1mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimter MV 1mg/500mg/0.2mg Tablet SR

Glimter MV 1mg/500mg/0.2mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with dietary modifications and physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevations. This formulation is unsuitable for type 1 diabetes treatment.
Glimter MV 1mg/500mg/0.2mg sustained-release tablets may cause common adverse reactions including hypoglycemia, nausea, diarrhea, dysgeusia, flatulence, abdominal pain, cephalalgia, dermatological reactions, and upper respiratory tract infections.
Patients with hypersensitivity to any Glimter MV 1mg/500mg/0.2mg Tablet SR ingredient or inactive component should not take this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Glimter MV 1mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and a heightened risk of lactic acidosis.
Glimter MV 1mg/500mg/0.2mg SR tablets may induce hypoglycemia. Low blood sugar symptoms can manifest as nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medicine. Ensure it remains inaccessible to children, pets, and others.
Glimter MV 1mg/500mg/0.2m...
82
MRP 100
18% off